Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

Ataxion

Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.

Acquired by Luc Therapeutics on March 07, 2017

Website: https://www.ataxiontherapeutics.com

Founded: April 01, 2013

Social:

Add Competitor

Startup	Industry	Description
NeuroX1	Pharmaceuticals & Biotechnology	The new standard in computational neuroscience - NeuroX1 is a computational drug design company bui ...
24Genetics	Pharmaceuticals & Biotechnology	DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
Turn Biotechnologies	Pharmaceuticals & Biotechnology	Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...

View more competitors»

Date	Round	Amount	Investors
Mar 01, 2014	Series A	$ 17,000,000	Biogen Idec Atlas Venture

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.

Person	Role	Period
David Grayzel	CEO	Unknown to Present
Joshua Resnick	Founder	Unknown to Unknown